ABVC BioPharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Frequently asked questions
To buy ABVC BioPharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ABVC BioPharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ABVC BioPharma Inc. is ABVC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ABVC BioPharma Inc. has its primary listing on NASDAQ (Small cap). You can trade ABVC BioPharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ABVC BioPharma Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include ABVC BioPharma Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like ABVC BioPharma Inc..